2018
DOI: 10.3892/mmr.2018.8882
|View full text |Cite
|
Sign up to set email alerts
|

Androgen receptor‑mediated upregulation of quaking affects androgen receptor‑related prostate cancer development and anti‑androgen receptor therapy

Abstract: The androgen receptor (AR) has a crucial role in prostate cancer. RNA-binding protein-mediated post-transcriptional regulation is important in the initiation and development of cancer. The present study attempted to elucidate the mutual association of AR and RNA-binding protein quaking (QKI) in the development of prostate cancer. Dual-luciferase reporter demonstrated that AR can positively regulate the expression of QKI in prostate cancer cell lines due to its effective transcription regulating function. In ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…When an RNA-binding protein called quaking (QKI) increases the concentration of heat shock protein 90, AR consequently becomes activated. As mentioned before, enhanced AR activity is associated with resistance phenotype; therefore, inhibition of QKI protein is capable of increasing cancerous cells’ sensitivity to bicalutamide . Contrarily, loss of AR expression or downstream signaling pathway may lead to bicalutamide resistance.…”
Section: Increased Ar Expressionmentioning
confidence: 88%
See 1 more Smart Citation
“…When an RNA-binding protein called quaking (QKI) increases the concentration of heat shock protein 90, AR consequently becomes activated. As mentioned before, enhanced AR activity is associated with resistance phenotype; therefore, inhibition of QKI protein is capable of increasing cancerous cells’ sensitivity to bicalutamide . Contrarily, loss of AR expression or downstream signaling pathway may lead to bicalutamide resistance.…”
Section: Increased Ar Expressionmentioning
confidence: 88%
“…As mentioned before, enhanced AR activity is associated with resistance phenotype; therefore, inhibition of QKI protein is capable of increasing cancerous cells' sensitivity to bicalutamide. 24 Contrarily, loss of AR expression or downstream signaling pathway may lead to bicalutamide resistance. It is believed that the explanation lies in cells having no dependency on AR signaling and hypermethylation of the AR gene promoter caused by genetic factors which can block AR expression.…”
Section: ■ Increased Ar Expressionmentioning
confidence: 99%
“…On the other hand, the QKI gene codifies for Quaking protein, which has important signal transduction and RNA activation functions. In PC, positive AR expression often co-exists with higher QKI expression levels [ 48 ]. The expression of FGD4 is also upregulated in PC and is associated with the increased aggressiveness of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…To form a ligand-AR complex and to control gene expression 2. To stimulate the proliferation of prostate cancer cells [12] ERα ER-positive breast cancer To stimulate the proliferation of ER-positive breast cancer cells [9] Integrin αv Prostate cancer To regulate tumor cell migration and growth [13] Integrin β1 Hepatocellular carcinoma To induce cell adhesion through PI3K/AKT signaling pathway [14] Integrin β1C Prostate cancer To be correlated with prostate cancer progression [15] Integrin α2 Prostate cancer To regulate metastasis mediated by adhesion to ColI through RANKL/RANK signaling [16] Table 1. Cont.…”
Section: Receptormentioning
confidence: 99%